Dechra Pharmaceuticals (DPH)

Sector:

Pharma and Biotech

Index:

FTSE 250

4,898.00p
   
  • Change Today:
    -132.00p
  • 52 Week High: 5,405.00
  • 52 Week Low: 3,182.00
  • Currency: UK Pounds
  • Shares Issued: 108.35m
  • Volume: 249,260
  • Market Cap: £5,307m
  • RiskGrade: 121
  • Beta: 0.25

Liberum cautious on durability of Covid boost for Dechra Pharmaceuticals

By Alexander Bueso

Date: Monday 01 Nov 2021

LONDON (ShareCast) - (Sharecast News) - Analysts at Liberum hiked their target price for shares of Dechra Pharmaceuticals but kept their recommendation at 'sell', telling clients that they struggled to justify such a lofty valuation.
In particular, the analysts questioned the sustainability of Covid-driven demand, which they said had lifted the entire companion animal market.

The day before, the veterinary pharmaceuticals and products specialist had turned in a solid set of full-year results, bolstered by a 26% surge in sales of Companion Animal Products.

And the company had seen a strong start to the 2022 fiscal year.

Hence their decision to raise their estimates and their target price with the latter rising from 3,110.0p to 3,960.0p.

Despite that "exceptional performance", the analysts said they could not justify a forward price-to-earnings multiple of 40.

They also noted that Dechra had flagged a softening in vet visits in the States.

Furthermore, market leader Zoetis was expecting trends to moderate, muddying the waters a bit when it came to the sustainability of the Covid-related boost to CAP.

Indeed, their new target remained some 20% below the actual share price despite factoring in sector-beating growth out to 2030 and moderating afterwards.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DPH Market Data

Currency UK Pounds
Share Price 4,898.00p
Change Today -132.00p
% Change -2.62 %
52 Week High 5,405.00
52 Week Low 3,182.00
Volume 249,260
Shares Issued 108.35m
Market Cap £5,307m
Beta 0.25
RiskGrade 121

DPH Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
86.60% above the market average86.60% above the market average86.60% above the market average86.60% above the market average86.60% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Income
61.11% below the market average61.11% below the market average61.11% below the market average61.11% below the market average61.11% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Growth
83.66% above the market average83.66% above the market average83.66% above the market average83.66% above the market average83.66% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 1
Strong Sell 1
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DPH Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Oct-21 04-Mar-21
Paid 19-Nov-21 07-Apr-21
Amount 29.39p 11.11p

Trades for 03-Dec-2021

Time Volume / Share Price
16:35 100,237 @ 4,898.00p
16:29 63 @ 4,898.00p
16:29 17 @ 4,898.00p
16:29 9 @ 4,888.00p
16:29 28 @ 4,898.00p

DPH Key Personnel

CEO Ian Page
CFO Paul Sandland

Top of Page